MedTrace Logo

Magseed Magnetic Marker Localization

NCT03020888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-02-04

Study results available
· View outcomes & findings →

Summary

The purpose of this post-marketing study is to provide prospective evidence that the Magseed and Sentimag® is effective for lesion localization in patients undergoing surgical excision of a breast lesion and to summarize measures of product safety and performance.

Conditions

  • Disorders of Breast
  • Breast Lesions

Interventions

DEVICE

Magseed and Sentimag

Magseed marker and Sentimag probe for lesion localization

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Endomagnetics Inc

    lead INDUSTRY

Principal Investigators

  • Kelly Hunt, MD · MD Anderson

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-02-28
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03020888 on ClinicalTrials.gov